Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
PK-101 by PMG PHARM for Osteoarthritis: Likelihood of Approval
PK-101 is under clinical development by PMG PHARM and currently in Phase III for Osteoarthritis. According to GlobalData, Phase III...